Neuropsychological test performance and self-reported cognitive functioning associated with work-related outcomes in occupationally active cancer survivors with cognitive complaints

Autor: Klaver, Kete M., Duijts, Saskia F.A., Geusgens, Chantal A.V., Aarts, Maureen J.B., Ponds, Rudolf W.H.M., van der Beek, Allard J., Schagen, Sanne B.
Přispěvatelé: Medical psychology, Public and occupational health, APH - Societal Participation & Health, APH - Mental Health, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy
Rok vydání: 2022
Předmět:
Zdroj: Journal of Cancer Survivorship. Springer New York
Journal of Cancer Survivorship-Research and Practice. Springer, Cham
Klaver, K M, Duijts, S F A, Geusgens, C A V, Aarts, M J B, Ponds, R W H M, van der Beek, A J & Schagen, S B 2022, ' Neuropsychological test performance and self-reported cognitive functioning associated with work-related outcomes in occupationally active cancer survivors with cognitive complaints ', Journal of Cancer Survivorship . https://doi.org/10.1007/s11764-022-01223-x
ISSN: 1932-2267
1932-2259
DOI: 10.1007/s11764-022-01223-x
Popis: Purpose: To assess cognitive functioning in occupationally active non-central nervous system cancer survivors with cognitive complaints using neuropsychological tests, and to investigate the association between (1) formally assessed cognitive functioning and self-reported work-related outcomes and (2) self-reported cognitive functioning at work and self-reported work-related outcomes. Methods: Baseline data of a multicenter, randomized controlled trial (n = 279) were used. Associations between neuropsychological test performance (Amsterdam Cognition Scan) and self-reported cognitive functioning (Cognitive Symptom Checklist-work) with work ability (Work Ability Index) and work functioning (Work Role Functioning Questionnaire) were examined using multivariate linear regression. Results: Thirty percent of cancer survivors had lower than expected performance on neuropsychological tests. Higher overall neuropsychological test performance was associated with better work ability (Cohen’s f2 = 0.014) and physical functioning at work (Cohen’s f2 = 0.13). Furthermore, higher motor performance was associated with better work ability (Cohen’s f2 = 0.018). In addition, self-reported work-related cognitive complaints were associated with self-reported work-related outcomes (Cohen’s f2 = 0.13–0.35). Conclusions: The percentage of cancer survivors with lower than expected performance on neuropsychological tests exceeded the percentage expected in a normal population. This neuropsychological test performance was weakly associated with various aspects of work ability and work functioning. Stronger associations were found between self-reported cognitive functioning at work with self-reported work-related outcomes. Implications for cancer survivors. A cognitive rehabilitation approach that specifically aims at reducing cognitive symptoms at work could be a valuable part of interventions that aim to improve work-related outcomes. Trial registration The study is registered at ClinicalTrials.gov (NCT03900806) at 03 April 2019 (current status: ongoing), https://clinicaltrials.gov/ct2/show/NCT03900806?term=NCT03900806&draw=2&rank=1
Databáze: OpenAIRE